Pulmonary arterial hypertension populations of special interest: portopulmonary hypertension and pulmonary arterial hypertension associated with congenital heart disease

Selexipag treatment for pulmonary arterial hypertension associated with congenital heart disease after defect correction: insights from the randomised controlled GRIPHON study

(2019) Maurice Beghetti et al.   EUROPEAN JOURNAL OF HEART FAILURE

Macitentan for the treatment of portopulmonary hypertension (PORTICO): a multicentre, randomised, double-blind, placebo-controlled, phase 4 trial

(2019) Olivier Sitbon et al.   Lancet Respiratory Medicine

Arrhythmias in adult patients with congenital heart disease and pulmonary arterial hypertension

(2018) Maria Drakopoulou et al.   HEART

Evaluation of Macitentan in Patients With Eisenmenger Syndrome

(2018) Michael A. Gatzoulis et al.   CIRCULATION

An overview of the 6th World Symposium on Pulmonary Hypertension

(2018) Nazzareno Galiè et al.   EUROPEAN RESPIRATORY JOURNAL

Long-term outcome in liver transplantation candidates with portopulmonary hypertension

(2017) Laurent Savale et al.   HEPATOLOGY

Survival in portopulmonary hypertension: Outcomes of the United Kingdom National Pulmonary Arterial Hypertension Registry

(2017) Sasiharan Sithamparanathan et al.   JOURNAL OF HEART AND LUNG TRANSPLANTATION

Portopulmonary Hypertension

(2017) Jason Watherald et al.   SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE

Potential Role of Patent Foramen Ovale in Exacerbating Hypoxemia in Chronic Pulmonary Disease

(2017) Michael E. Layoun et al.   TEXAS HEART INSTITUTE JOURNAL

Potential Role of Patent Foramen Ovale in Exacerbating Hypoxemia in Chronic Pulmonary Disease

(2017) Michael E. Layoun et al.   TEXAS HEART INSTITUTE JOURNAL

Severe Pulmonary Arterial Hypertension in Patients Treated for Hepatitis C With Sofosbuvir

(2016) Sébastien Renard et al.   CHEST

International Liver Transplant Society Practice Guidelines

(2016) Michael J. Krowka et al.   TRANSPLANTATION

Effectiveness of Phosphodiesterase-5 Inhibitor Therapy for Portopulmonary Hypertension

(2015) Jolene H Fisher et al.   Canadian Respiratory Journal

Patent foramen ovale in liver transplant recipients does not negatively impact short-term outcomes

(2015) Monia E. Werlang et al.   CLINICAL TRANSPLANTATION

2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension

(2015) Nazzareno Galiè et al.   EUROPEAN HEART JOURNAL

Pulmonary arterial hypertension in patients treated with interferon: TABLE 1

(2015) Laurent Savale et al.   EUROPEAN RESPIRATORY JOURNAL

Combining bosentan and sildenafil in pulmonary arterial hypertension patients failing monotherapy: real-world insights

(2015) Fabio Dardi et al.   EUROPEAN RESPIRATORY JOURNAL

Bosentan added to sildenafil therapy in patients with pulmonary arterial hypertension

(2015) Vallerie McLaughlin et al.   EUROPEAN RESPIRATORY JOURNAL

Riociguat for pulmonary arterial hypertension associated with congenital heart disease

(2015) Stephan Rosenkranz et al.   HEART

Selexipag for the Treatment of Pulmonary Arterial Hypertension

(2015) Olivier Sitbon et al.   NEW ENGLAND JOURNAL OF MEDICINE

Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension

(2015) Nazzareno Galiè et al.   NEW ENGLAND JOURNAL OF MEDICINE

MELD Exceptions for Portopulmonary Hypertension: Current Policy and Future Implementation

(2014) D. S. Goldberg et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Pulmonary arterial hypertension in patients treated with interferon

(2014) Laurent Savale et al.   EUROPEAN RESPIRATORY JOURNAL

Contemporary prevalence of pulmonary arterial hypertension in adult congenital heart disease following the updated clinical classification

(2014) Annelieke C.M.J. van Riel et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Pulmonary arterial hypertension associated with congenital heart disease: Recent advances and future directions

(2014) Michael A. Gatzoulis et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Comorbid Conditions and Outcomes in Patients With Pulmonary Arterial Hypertension

(2013) Abby D. Poms et al.   CHEST

Current era survival of patients with pulmonary arterial hypertension associated with congenital heart disease: a comparison between clinical subgroups

(2013) A. Manes et al.   EUROPEAN HEART JOURNAL

Pulmonary hypertension related to congenital heart disease: a call for action

(2013) K. Dimopoulos et al.   EUROPEAN HEART JOURNAL

Early Initiation of Prostacyclin in Portopulmonary Hypertension: 10 Years of a Transplant Center’s Experience

(2013) Rana L. A. Awdish et al.   LUNG

Macitentan and Morbidity and Mortality in Pulmonary Arterial Hypertension

(2013) Tomás Pulido et al.   NEW ENGLAND JOURNAL OF MEDICINE

Riociguat for the Treatment of Pulmonary Arterial Hypertension

(2013) Hossein-Ardeschir Ghofrani et al.   NEW ENGLAND JOURNAL OF MEDICINE

Extracorporeal Membrane Oxygenation Rescue Therapy in a Case of Portopulmonary Hypertension During Liver Transplantation: A Case Report

(2013) C. Stratta et al.   TRANSPLANTATION PROCEEDINGS

Portopulmonary Hypertension

(2012) Olivier Sitbon et al.   CHEST

Efficacy, safety and pharmacokinetics of bosentan in portopulmonary hypertension

(2012) L. Savale et al.   EUROPEAN RESPIRATORY JOURNAL

Portopulmonary Hypertension

(2011) Michael J. Krowka et al.   CHEST

Cardiovascular Risk Assessment of the Liver Transplant Candidate

(2011) Zankhana Raval et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Pulmonary Complications of Congenital Heart Disease

(2011) F. Healy et al.   Paediatric Respiratory Reviews

Safety and Efficacy of Ambrisentan for the Treatment of Portopulmonary Hypertension

(2010) Rodrigo Cartin-Ceba et al.   CHEST

Tadalafil Therapy for Pulmonary Arterial Hypertension

(2009) Nazzareno Galiè et al.   CIRCULATION

Improved Survival Among Patients With Eisenmenger Syndrome Receiving Advanced Therapy for Pulmonary Arterial Hypertension

(2009) Konstantinos Dimopoulos et al.   CIRCULATION

Portopulmonary Hypertension

(2008) Jérôme Le Pavec et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Treatment of patients with mildly symptomatic pulmonary arterial hypertension with bosentan (EARLY study): a double-blind, randomised controlled trial

(2008) N Galiè et al.   LANCET